22 results
8-K
EX-10.3
XENE
Xenon Pharmaceuticals Inc
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
permission from the Company. This does not restrict you from performing reasonable volunteer activities; however, you must obtain the consent … of Volunteer, Board and Other External Commitments
Position
Organization
Length of Appointment/ Engagement
Consultant Physician
UBC
Open ended
Clinical
8-K
EX-10.2
XENE
Xenon Pharmaceuticals Inc
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
reasonable volunteer activities; however, you must obtain the consent of the Company if you wish to serve on a board of directors or advisory board …
SCHEDULE B
Disclosure of Volunteer, Board and Other External Commitments
Position
Organization
Length of Appointment/ Engagement
Board member
8-K
EX-10.4
0q7zamq xcht6p
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.6
00m k1g9m
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.2
dw55i 6izg3jl
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.7
bif3nhwi4911qpxpv
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
2lhx0
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.3
upvqeaean7
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.4
7s9zj1w35 74en6tly1
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.5
cqr f2c2v
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
S-1/A
EX-10.9
ldqjiwr1p5zh97ni63ml
6 Oct 14
IPO registration (amended)
12:00am
S-1/A
EX-10.10
ledu2v6cei
6 Oct 14
IPO registration (amended)
12:00am
S-1/A
EX-10.11
kxgevvr
6 Oct 14
IPO registration (amended)
12:00am